2 models fit Celsius Holdings Inc. Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Premium(i)
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionCelsius Holdings Inc. Common Stock (CELH)
Fair value (2 models)
$21.72
ACCE price target
$30.00
Rating
Overvalued
Horizon
12 months
Fair value published on 19 Oct 2026, 19:04 CEST; previously $21.14 since 15 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $38.00 since 18 May 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $28.47 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
31.1% above
-23.7% to fair value
ACCE score
42
out of 100
Analysts
75% buy
24 covering
P/E
123.8x
forward 16.8x
1-year return
-54.0%
Dividend yield
0.00%
Celsius Holdings Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Celsius Holdings makes Celsius-branded functional energy drinks, sold through grocery, mass and convenience channels, and since its 2025 acquisition of Alani Nu it also owns that brand's fast-growing energy line. The company's edge is a 48.8% gross margin and 19.1% operating margin in a category where scale has usually meant margin compression, which suggests its distribution and brand pricing are holding up. Revenue growth of 10.6% is modest for a stock carrying a 122.4 trailing P/E, but the forward P/E of 16.9 implies the market expects earnings to catch up sharply as acquisition and integration costs roll off. The thesis hinges on whether Alani Nu's velocity and the combined portfolio translate into the earnings step-up the forward multiple assumes. The 5.1% ROE and lack of index membership at a 7.1 billion dollar market cap mean the market has not yet rewarded the earnings inflection, so this is worth a deeper look at the integration and margin trajectory before deciding anything further.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Earnings collapse vs revenue growth
Earnings down 56.9% YoY while revenue up 10.6%. Margin compression or one-time charges suggest profitability deterioration despite top-line resilience.
high
ACCE score collapse
Score fell 15 points in 90 days (57 to 42). Quality score 68 masks severe valuation (42) and momentum (17) weakness.
moderate
Valuation disconnect at peak multiples
P/E 124.3 on 4.2% net margin and negative earnings momentum. Forward P/E 16.9 implies sharp earnings recovery; execution risk is material.
moderate
High short interest amid deterioration
12.4% short interest combined with 15-point score decline and earnings miss suggests bearish thesis gaining traction. Monitor for forced liquidation or further downside.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Strong free cash flow of $323M and 4.5% yield provide financial flexibility and shareholder returns.
Forward P/E of 16.9x trades below the 18.1x sector median, offering valuation cushion.
Why it could disappoint
Year-over-year revenue growth of 10.6% has collapsed from the 80.7% five-year average, signaling momentum loss.
Consensus fair value of $21.49 sits 24.8% below the current $28.58 share price, indicating overvaluation.
Latest earnings missed expectations by 14.3%, raising questions about management's ability to deliver guidance.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where CELH's valuation models land
Price
$28.47
Model fair value
$21.72
Model range
$16.94 to $26.50
Fair value $21.72
Price $28.47
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores